Results 81 to 90 of about 59,855 (258)

Game Changers in the Treatment of and Engagement With Persons Living With Mental Health and Substance Use Disorders: The Role of the Nurse

International Journal of Mental Health Nursing, Volume 35, Issue 2, April 2026.
ABSTRACT The game changers in mental health and substance use disorder treatment have been shaped by historical sea changes marked by transformative advancements that have significantly enhanced patient care. Breakthroughs in psychotherapy, psychosurgery and psychopharmacology have each contributed to reshaping clinical practices, especially the ...
Arlene Kent‐Wilkinson, Sudor Ogunwemimo, Eileen Zaba   +2 more
wiley   +1 more source

Beneficial effect of candesartan and lisinopril against haloperidol-induced tardive dyskinesia in rat

Journal of the Renin-Angiotensin-Aldosterone System, 2015
Introduction: Tardive dyskinesia is a serious motor disorder of the orofacial region, resulting from chronic neuroleptic treatment of schizophrenia. Candesartan (AT1 antagonist) and lisinopril (ACE inhibitor) has been reported to possess antioxidant and ...
K. Thakur, A. Prakash, R. Bisht, P. Bansal   +3 more
semanticscholar   +1 more source

Tardive Dyskinesia Associated with Paliperidone Palmitate

Psychiatry and Behavioral Sciences, 2016
-Dear Editor, Paliperidone is an atypical antipsychotic drug formed by one of the active metabolites of risperidone, 9-hydroxirisperione.1 The drug demonstrates its effects by antagonizing central dopamine type-2 (D2) and serotonin type-2 (5HT2A ...
Sevda Korkmaz, Burcu Gundoğan
doaj   +1 more source

Minimal Clinically Important Difference in AIMS Score Based on CGIC and PGIC in Patients With Tardive Dyskinesia Treated With Deutetrabenazine [PDF]

, 2021
Hadas Barkay, Robert A. Hauser, Amanda Wilhelm, Maria Wieman, Mark Forrest Gordon, Juha‐Matti Savola   +5 more
openalex   +1 more source

Association Study Indicates a Protective Role of Phosphatidylinositol-4-Phosphate-5-Kinase against Tardive Dyskinesia

International Journal of Neuropsychopharmacology, 2015
Background: Tardive dyskinesia is a disorder characterized by involuntary muscle movements that occur as a complication of long-term treatment with antipsychotic drugs.
O. Fedorenko, A. Loonen, F. Lang, Valentina A. Toshchakova, E. G. Boyarko, A. Semke, N. Bokhan, N. Govorin, L. Aftanas, S. Ivanova   +9 more
semanticscholar   +1 more source

Genome wide study of tardive dyskinesia in schizophrenia [PDF]

, 2021
Keane Lim, Max Lam, Clement C. Zai, Jenny Tay, Nina Karlsson, Smita N. Deshpande, B.K. Thelma, Norio Ozaki, Toshiya Inada, Kang Sim, Siow‐Ann Chong, Todd Lencz, Jianjun Liu, Jimmy Lee   +13 more
openalex   +1 more source

Lingual Dyskinesia as the Presenting Feature of Acquired Demyelinating Syndrome: A Case Report and Review of Differential Diagnoses

Journal of Paediatrics and Child Health, Volume 62, Issue 6, Page 1060-1065, June 2026.
Briana Davis, Ahmed Kaki, Eppie M. Yiu, Emma Macdonald‐Laurs   +3 more
wiley   +1 more source

A Case of Tardive Akathisia and Dyskinesia [PDF]

Düşünen Adam Psikiyatri ve Nörolojik Bilimler Dergisi, 2007
Various drugs, mainly antipsychotics in psychiatry may induce movement disorders. These acute or tardive type movement disorders could either be in hypokinetic or in hyperkinetic form. There are other movement disorders in tardive type (e.g.
Timuçin Oral, Erhan Kurt, Aslı Kalkay, Oya Öztürk, Feriha Özer   +4 more
doaj  

Incidence of tardive dyskinesia: a comparison of long-acting injectable and oral paliperidone clinical trial databases

International journal of clinical practice, 2014
To assess the tardive dyskinesia (TD) rate in studies of once‐monthly long‐acting injectable (LAI) paliperidone palmitate (PP) and once‐daily oral paliperidone extended release (Pali ER).
S. Gopal, H. Xu, C. Bossie, J. Burón, D. Fu, A. Savitz, I. Nuamah, D. Hough   +7 more
semanticscholar   +1 more source

A Case Report of Lithium-Induced Tardive Dyskinesia

Journal of Health Science and Medical Research (JHSMR)
Our case involves an elderly patient with bipolar disorder with a history of long-term low-dose lithium monotherapy (600 mg/day) who subsequently developed tardive dyskinesia as an adverse drug reaction.
Chutimon Boonrod, Keerati Pattanaseri, Juthawadee Lortrakul   +2 more
doaj   +1 more source